CDSCO Consultant for Medical Devices in India | 2026 Guide to Licences, Timelines and the Right Partner
Need a CDSCO consultant for medical devices in India? See licence routes, timelines, costs and 2026 rule changes, and avoid the errors that stall approvals.
CDSCO Consultant for Medical Devices in India - Regulatory Compliance & Licensing Guide 2026
Most Indian medical device approvals don't stall because of the device. They stall because of the file. A wrong risk class, an expired Free Sale Certificate or a device description that doesn't match the label can push a launch back by months. A CDSCO consultant for medical devices in India exists to catch those problems before the regulator does.
The stakes keep rising. The Government of India's National Medical Devices Policy 2023 expects the sector to grow from about $11 billion to $50 billion by 2030. Regulatory oversight has grown with it, and every notified device now needs medical device registration in India or a licence before it reaches a hospital or pharmacy.
In this guide, you will learn how CDSCO classifies devices, which licence your product needs, what a consultant actually does, realistic timelines and costs, the 2026 rule changes, and how to pick a partner you won't regret hiring.
What Does a CDSCO Consultant for Medical Devices in India Do?
A CDSCO consultant for medical devices in India is a regulatory specialist who plans, prepares and manages your application to the Central Drugs Standard Control Organisation (CDSCO). CDSCO is India's national regulator for drugs, cosmetics and medical devices. The consultant translates your engineering and quality data into the format the regulator expects.
The work starts before anyone files a form. A good regulatory affairs consultant first confirms that your product legally counts as a medical device. Next, they assign the correct risk class under the Medical Devices Rules, 2017 and map the licence route. Dossier work begins only after those decisions hold up.
Day to day, the consultant writes or reviews technical files, coordinates test reports, files applications online, answers CDSCO queries and prepares your team for site audits. After approval, the same partner tracks retention fees, change notifications and adverse event reporting.
You are really paying for fewer surprises. An experienced consultant knows which documents CDSCO reviewers question most, and fixes them before submission rather than after a query letter arrives.
How CDSCO Regulates Medical Devices in India
India runs a risk-based system under the Medical Devices Rules 2017 (MDR 2017). Your route depends on the risk class and on whether you make or import the device.
The Four Risk Classes
CDSCO sorts devices into Class A, B, C and D, using principles that follow the global IMDRF risk model. Class A covers low-risk products such as clinical thermometers. Class D covers the highest-risk products, such as heart valves. In vitro diagnostic (IVD) kits follow a parallel A-to-D scheme, which our IVD regulatory team handles separately.
Correct medical device classification drives everything else: the reviewing authority, the form, the evidence and the fee. For products that sit between categories, read our guide on borderline product classification strategy.
| Class | Risk Level | Example Devices | Manufacturing Licence (Apply → Grant) | Who Licenses Manufacture |
|---|---|---|---|---|
| A | Low | Clinical thermometers, tongue depressors | MD-3 → MD-5 | State Licensing Authority |
| B | Low to moderate | Hypodermic needles, suction equipment | MD-3 → MD-5 | State Licensing Authority |
| C | Moderate to high | Ventilators, bone fixation plates | MD-7 → MD-9 | Central Licensing Authority |
| D | High | Heart valves, implantable defibrillators | MD-7 → MD-9 | Central Licensing Authority |
| All (Import) | Any | Any imported device | MD-14 → MD-15 | Central Licensing Authority |
Central vs State Licensing Authority
The Central Licensing Authority, headed by the Drugs Controller General of India, handles all imports, Class C and D manufacturing, clinical investigations and new devices without a predicate. State Licensing Authorities handle Class A and B manufacturing licences within their state.
Imports follow one route regardless of class. Importers file Form MD-14 on the SUGAM portal and receive a CDSCO import license in Form MD-15. Class A devices that are non-sterile and non-measuring no longer need a licence, but they still need online registration.
Why Hire a CDSCO Consultant for Medical Devices in India in 2026?
You can file on your own, and some companies do. The better question is what a stalled file costs you in lost sales, idle stock and distributor patience.
CDSCO reviews on paper. Reviewers can't see your cleanroom or your engineers' skill. They see only the dossier. When that dossier contradicts itself, the regulator raises a query, and every query round adds weeks. Wrong classification, weak Power of Attorney wording and outdated Free Sale Certificates trigger many of these queries.
A specialist earns the fee in three places: choosing the right route the first time, building documents that survive review, and answering queries quickly with technical evidence. The comparison below shows how the common options stack up.
| Factor | DIY Filing | Generic Licensing Agency | Specialist CDSCO Consultant |
|---|---|---|---|
| Classification accuracy | Depends on in-house knowledge | Often template-based | Justified against MDR 2017 rules and predicates |
| Dossier quality | Variable | Copy-paste formats | Device-specific technical files |
| Query handling | Slow, learning on the job | Forwards queries back to you | Drafts technical responses |
| Audit readiness | Rarely prepared | Usually not covered | Mock audits and gap closure |
| After approval | Ad hoc | Ends at licence grant | Renewals, changes, vigilance |
| Best fit | Teams with regulatory staff | Simple Class A registrations | Class B–D, imports, new devices |
Core Services a Medical Device CDSCO Consultant Should Offer
Scope matters more than price. These five service areas separate a full regulatory partner from a form-filling service.
Classification and Regulatory Strategy
Everything begins with intended use. The consultant reviews your claims, labels and instructions for use, assigns a class, and checks whether a predicate device already exists in India. If no predicate exists, the product follows the new-device route, which needs separate permission and may need clinical data.
Device Master File and Plant Master File
The device master file (DMF) describes the product: design, materials, risk analysis, verification tests, biocompatibility, sterilisation and labelling. The plant master file (PMF) describes the site that makes it. Our technical documentation consulting service builds both in the format MDR 2017 sets out.
Import Licensing and Indian Authorized Agent Support
Overseas manufacturers can't apply to CDSCO directly. They appoint an Indian Authorized Agent through a power of attorney. The agent must hold a valid licence to sell or manufacture devices in India and carries legal responsibility for the product here.
Manufacturing Licences and QMS Audits
Indian manufacturers need a quality system that meets the Fifth Schedule of MDR 2017, which tracks closely with ISO 13485 certification. Our CDSCO manufacturing licence guide explains how to prepare product and site evidence together.
Post-Approval Compliance
Approval starts a new set of duties. You pay a retention fee every five years, notify CDSCO of changes, report adverse events and run post-market surveillance. Our audit and compliance support team sets these routines up so they survive staff changes.
Step-by-Step: How a CDSCO Consultant for Medical Devices in India Gets You Approved
A well-run project follows a clear sequence. The durations below are typical planning ranges, not guarantees, since CDSCO workload and query rounds vary.
| Step | What Happens | Typical Duration |
|---|---|---|
| 1. Gap assessment | Review device data, claims and existing certificates | 1–2 weeks |
| 2. Classification and pathway | Assign class, check for a predicate, choose the licence route | 1–2 weeks |
| 3. Testing and evidence | Coordinate performance, electrical safety and biocompatibility tests | 4–12 weeks |
| 4. Dossier build | Write the DMF, PMF, labels and declarations | 3–6 weeks |
| 5. SUGAM portal filing | Register the applicant, upload forms and pay government fees | About 1 week |
| 6. Review and queries | Answer CDSCO queries and host the site audit if required | 2–6 months |
| 7. Grant and launch | Receive the licence and set up surveillance and renewals | Ongoing |
Step 3 often decides the whole schedule. Test labs book up, and a biocompatibility gap found late can add a month. Our article on ISO 10993 biological evaluation shows how to define the testing question before you order tests.
Wireless products carry one more step. Devices with Bluetooth or Wi-Fi modules usually need WPC approval for wireless medical devices alongside the CDSCO licence, so plan both in parallel.
How Long Does a CDSCO Consultant for Medical Devices in India Take, and What Does It Cost?
Plan in months, not weeks. For a standard import licence, most applicants should budget four to nine months from a complete file to grant. Class C and D devices and new devices without a predicate usually land at the longer end. Class C and D manufacturing licences can take longer still, because they include a CDSCO site inspection.
Your realistic CDSCO approval timeline depends on three things you control: how complete the dossier is on day one, how quickly your team supplies data for queries, and whether test reports arrive on schedule.
Budget in three parts. Government fees depend on the class, the number of sites and the number of devices, and CDSCO publishes them in the Second Schedule of MDR 2017. Grouping products correctly as a family or system can reduce those fees. Testing costs depend on the standards that apply to your device.
Consultant fees vary with class and scope. A fixed-scope quote with named deliverables is far easier to compare than an open hourly rate. Be wary of quotes far below the market for Class C or D work, since they usually mean templated files and more query rounds later.
2026 CDSCO Rule Changes Your Consultant Should Track
India's device rules keep moving, and a good consultant watches the Gazette so you don't have to. Four developments matter this year.
First, a 2026 amendment to Rule 63 adds European Union countries to the list of reference markets that CDSCO recognises. EU-approved devices can now lean on that approval in the same way US, UK, Australian, Canadian and Japanese approvals already could. Our breakdown of the India MDR 2026 Rule 63 amendment explains the impact for EU brands and Indian importers.
Second, the April 2026 draft amendments proposed changes on constitution-change filings, labelling for outsourced sterilisation and testing fees, as Asia Actual summarised.
Third, a draft proposal reported by CEHTRA would make a notified-body QMS audit mandatory before a manufacturing licence is granted. If that becomes final, audit readiness moves earlier in every project.
Finally, CDSCO added a risk classification module to its online system in late 2025 for novel devices not yet on its classification lists. Drafts can change before final notification, so confirm current status before you plan around them.
Choosing a CDSCO Consultant: Overseas Manufacturers vs Indian Startups
Overseas Manufacturers
Foreign companies need a consultant who can set up or vet the Indian Authorized Agent, manage the Free Sale Certificate and reference-country approvals, and adapt labels for India. Labels must show India-specific details such as the importer's name and import licence number. A consultant who also works on FDA and EU MDR files can reuse your existing evidence instead of rebuilding it. Our guide to global MedTech strategy with reusable evidence covers that approach.
Indian Startups and MSMEs
Startups usually need help earlier. Before full approval, you can apply for a test licence (Form MD-12, granted in Form MD-13) to make small quantities for testing, evaluation and demonstrations. A consultant also helps you build an ISO 13485 quality system that fits a small team. Our piece on ISO 13485 documentation people can actually use is a practical starting point.
How to Choose the Right CDSCO Consultant for Medical Devices in India
Ask for evidence, not promises. Use these checks before you sign any engagement letter:
- Ask for approvals in your device class and category, because Class D implant experience differs sharply from Class A consumables.
- Request a written classification rationale in the proposal, since a consultant who can't justify your class early will struggle later.
- Confirm who drafts responses to CDSCO queries, and insist that a technical specialist does it rather than an account manager.
- Check whether the scope covers audit preparation, SUGAM portal registration and post-approval changes, not just the initial filing.
- Look for international experience with FDA, EU MDR or MDSAP if you plan to export, so one evidence base serves several markets.
- Get a fixed-scope quote with named deliverables and realistic timelines, and treat any "guaranteed approval date" as a warning sign.
- Review published case studies and speak to at least one past client about query handling and communication.
You can review how NKB Regovanta handles these projects in our client case studies.
Common Mistakes That Delay CDSCO Approval
Most delays trace back to a short list of avoidable errors. Wrong classification tops it, because it sends you down the wrong form, fee and evidence route. Fixing it mid-review often means withdrawing and refiling.
Document inconsistency comes next. When the device name, model numbers or intended use differ between the DMF, the label and the Free Sale Certificate, reviewers notice. Expired or incorrectly notarised certificates cause the same trouble.
Late testing is the third common error. Teams often submit before key test reports arrive, then scramble when CDSCO asks for them. Finally, many companies treat approval as the finish line and miss retention fees or change notifications. Our article on turning compliance records into regulatory evidence shows how to keep files audit-ready long after the grant.
What Reddit Communities Discuss About CDSCO Approvals
Online communities give a useful, unfiltered view of what founders and regulatory professionals struggle with. The r/regulatoryaffairs community often hosts questions from RA professionals about Indian submissions and career moves into device regulation.
Device engineers and founders discuss product and market-entry questions in r/MedicalDevices, while Indian founders raise licensing costs and timelines in r/StartUpIndia. You can also run a site-wide Reddit search for CDSCO medical device licences to see current posts and comment threads.
Treat forum advice as a starting point, not a legal opinion. Rules change, and a comment from two years ago may describe a process that no longer exists.
Frequently Asked Questions About CDSCO Consultants for Medical Devices in India
What is a CDSCO consultant for medical devices in India?
A CDSCO consultant for medical devices in India is a regulatory specialist who helps manufacturers and importers get licences from the Central Drugs Standard Control Organisation. The consultant classifies the device, picks the right licence route, prepares the device master file and plant master file, files the application online and answers regulator queries. Many consultants also prepare sites for audits and manage post-approval duties such as retention fees, change notifications and adverse event reporting. The goal is a complete, consistent file that clears review with fewer query rounds.
How long does CDSCO medical device registration take with a consultant?
Most CDSCO medical device registration projects take four to nine months from a complete dossier to licence grant. Simple Class A and B products sit at the shorter end. Class C and D devices, new devices without an Indian predicate and manufacturing licences that need a site inspection usually take longer. A consultant can't control CDSCO's workload, but they can cut avoidable delays by filing a complete dossier and answering queries fast. Read our CDSCO registration guidelines for route-by-route detail.
How much does a CDSCO consultant for medical devices in India charge?
Fees for a CDSCO consultant for medical devices in India vary with device class, the number of products and the scope of work. A Class A registration costs far less than a Class D import licence with clinical evidence review. Government fees and testing costs sit on top of consultant fees. Ask for a fixed-scope proposal that lists deliverables, such as classification rationale, DMF, PMF, filing and query support, so you can compare quotes fairly rather than on headline price alone.
What is the difference between a CDSCO consultant and an Indian Authorized Agent?
An Indian Authorized Agent is the legal licence holder who represents an overseas manufacturer before CDSCO and carries responsibility for the product in India. A CDSCO consultant is a technical advisor who prepares the strategy and documents. Some firms offer both roles, while others work alongside an existing agent or distributor. Foreign manufacturers must have an authorised agent, but the consultant is optional. In practice, most overseas companies use both to avoid errors in the CDSCO import license application.
Do I need a CDSCO consultant if my device already has CE marking or FDA clearance?
Foreign approvals help, but they don't replace a CDSCO consultant for medical devices in India. CDSCO still expects an India-specific dossier, correct local classification, India labelling and a licensed authorised agent. Approval in reference markets such as the US or, since the 2026 Rule 63 amendment, the EU can reduce local clinical evidence demands. A consultant knows how to reuse your CE or FDA evidence without copying documents that don't fit Indian formats. Our CDSCO registration services page explains how we adapt global files.
Can a startup get a CDSCO test licence before full manufacturing approval?
Yes. Indian startups can apply for a test licence in Form MD-12, which CDSCO grants in Form MD-13. It lets you make small quantities of a device for testing, evaluation, clinical investigation or demonstration, but not for sale. A CDSCO consultant for medical devices in India can file the test licence early so development and regulatory work run in parallel. You'll still need a full manufacturing licence before commercial sale, and the quality system you build now should already point towards ISO 13485.
Questions & Answers
Who regulates medical devices in India?
The Central Drugs Standard Control Organisation (CDSCO) regulates medical devices in India under the Medical Devices Rules, 2017. The Drugs Controller General of India heads it. CDSCO licenses all imports and Class C and D manufacturing, while State Licensing Authorities license Class A and B manufacturing within each state.
Do Class A medical devices need a CDSCO licence?
Class A devices that are non-sterile and non-measuring don't need a licence, but they still need registration on CDSCO's online system. Class A devices that are sterile or have a measuring function still need a licence. A consultant can confirm which group your product falls into before you file anything.
What documents does a CDSCO consultant need to start work?
A CDSCO consultant usually needs your intended use statement, labels and instructions for use, design and risk documents, test reports, quality system certificates and any existing foreign approvals. Overseas companies also share their Free Sale Certificate and power of attorney drafts. With these, the consultant can confirm class and route within one or two weeks.
Where can I find a reliable CDSCO consultant for medical devices in India?
Look for a CDSCO consultant for medical devices in India with published case studies, experience in your device class and a clear fixed-scope proposal. Firms such as NKB Regovanta combine CDSCO, FDA and EU MDR work, which helps if you plan to sell in several markets from one evidence base.
Getting a device into Indian hospitals takes more than a completed form. It takes the right class, the right route and a dossier that answers reviewers' questions before they ask them. Working with an experienced CDSCO consultant for medical devices in India turns a months-long guessing game into a planned project with clear milestones. NKB Regovanta has supported regulatory and quality projects since 2018 across CDSCO, US FDA and EU MDR. Explore our India CDSCO registration services or book a consultation with our regulatory team to map your device's route. Choosing the right CDSCO consultant for medical devices in India today is the fastest way to protect your launch date tomorrow.
Frequently Asked Questions
NKB Regulatory Experts
Verified Regulatory ExpertM.Pharm, RAC (Global Regulatory Affairs Certified)
Senior Regulatory Affairs & Quality Assurance Specialists at NKB Regovanta Solutions Pvt. Ltd., guiding MedTech manufacturers worldwide across CDSCO, US FDA, EU MDR, and ISO 13485 compliance.
Need Fast CDSCO / FDA / EU MDR Clearance?
Our specialists handle classification, Device Master Files (DMF), quality systems (ISO 13485), and regulatory submissions worldwide.
Facing medical device compliance bottlenecks or Notified Body review findings?
NKB Regovanta conducts thorough regulatory gap assessments, dossier remediation, and health authority liaison to secure market approvals with confidence.